Cost-effectiveness analysis of Cardioform vs. Amplatzer: concerns regarding methodological transparency and interpretation of clinical results
Open access0 citations
Abstract
Volpi et al. recently published an article evaluating the cost-effectiveness of patent foramen ovale (PFO) management strategies, comparing closure with the Cardioform vs. Amplatzer device for seco...
// Source
Authors: David W. Hutton, Anne M. Ryschon, Scott Goates, Jan B. Pietzsch, Lars Søndergaard
Institutions: University of Michigan, Abbott (United States), Data One Global (United States), Abbott (Canada), Abbott Fund